What is PHAR's P/E ratio?

PHARMING GROUP NV (PHAR) currently trades at a P/E ratio of 49.45.

PHARMING GROUP NV reports a Return on Equity (ROE) of 4.58%.

What is PHAR's dividend yield?

PHARMING GROUP NV offers a dividend yield of 0.00%.

What is PHAR's Deepscope Quality Score?

Deepscope rates PHAR's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PHAR?

Deepscope's AI Timing Score for PHAR is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PHAR belong to?

PHARMING GROUP NV is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น PHAR (NASDAQ) | PHARMING GROUP NV – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-03 | FS: 2026-03-31)

PHAR

PHARMING GROUP NV

US:NASDAQ STOCK Healthcare >> Biotechnology News 95

USD 12.24

-0.04 (-0.33%) Day Change

Watchlist Portfolio Compare Chart

49.45

P/E

0.38

D/E

4.6%

ROE

2.5%

ROA

0.00%

Div Yield

-0.47

PEG

PHARMING GROUP NV
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 12.24 Price -0.04 (-0.33%) Day Change	NEWS SCORE: 95

PHAR มีคุณภาพโดยรวมพอใช้ ( คะแนนปัจจัยพื้นฐาน = 62) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: P/E ratio ค่อนข้างสูง
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	95
Magic Formula Rank by ROA	3012
Magic Formula Rank by ROE	3012
Magic Formula Rank by ROIC	2548
Price	12.24
PBV / Sector	3.22 / 4.48
Earning Per Share	0.17

PE / Sector	49.45 / 16.68
PEG or PE/Growth / Sector	-0.47 / 0.53
Average 1M Daily Value	0.22 M GREAT
Average 1W Daily Value	0.18 M GREAT

ปัจจัยทางเทคนิค

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	3.34 / 450.37
NPM Average (%) / Sector	0.49 / -1,506.30
NPM Change Average (%) / Sector	12.30 / 4,941.44 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	2.52 / 30.83
ROA Average (%) / Sector	0.21 / -347.12
ROA Change Average (%) / Sector	19.98 / 5,126.35 GOOD
ROE (%) / Sector	4.58 / -3.04
ROE Average (%) / Sector	0.42 / 40.76
ROE Change Average (%) / Sector	15.93 / 2,110.63 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-04 09:24:20
Symbol	PHAR
Name	PHARMING GROUP NV
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	70.63 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	867.28 / 8,483.11

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Darwinweg 24, Leiden, Netherlands, 2333 CR

Phone: 31 71 524 7400

Website: https://www.pharming.com

Employees: 407

Sector: Healthcare >> Biotechnology

Description: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.